Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cara Therapeutics (NQ: CARA )

0.7881 +0.0099 (+1.27%)
Streaming Delayed Price Updated: 1:06 PM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cara Therapeutics

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Cara Therapeutics: Return On Capital Employed Insights
During Q1, Cara Therapeutics (NASDAQ:CARA) brought in sales totaling $1.94 million. However, earnings decreased 130.09%, resulting in a loss of $23.56 million. Cara Therapeutics... 
Via Benzinga
Is Cara Therapeutics a Buy for Summer 2021?
The future of this troubled clinical-stage biotech rests on a single drug candidate that management hopes will treat an extremely common condition. 
Via The Motley Fool
Is Cara Therapeutics a Buy?
Maybe, if you're itching to speculate. 
Via The Motley Fool
Cannabis Stock Gainers And Losers From May 11, 2021
GAINERS: Claritas Pharmaceuticals (... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Stocks That Hit 52-Week Highs On Friday
During the morning session on Friday, 178 stocks hit new 52-week highs. Noteworthy Points: Microsoft (NASDAQ:MSFT) was the largest firm on a market cap basis to set... 
Via Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
Via Benzinga
Exposures COVID-19 Product Safety
Cara Therapeutics Inc (CARA) Q1 2021 Earnings Call Transcript
CARA earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Cara Therapeutics: Q1 Earnings Insights
Shares of Cara Therapeutics (NASDAQ:CARA) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 24.19% year over year... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT).... 
Via Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Cannabis Stock Gainers And Losers From April 30, 2021
GAINERS: Rhinomed (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
65 Biggest Movers From Yesterday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) jumped 33.1% to settle at $3.34 on Thursday as the company said it has been named as sponsor related to 4 SPACs. Takung Art Co., Ltd. (... 
Via Benzinga
Cannabis Stock Gainers And Losers From April 29, 2021
GAINERS: RIV Capital (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Mid-Afternoon Market Update: Dow Gains 175 Points; JAKKS Pacific Shares Climb After Q1 Results
Toward the end of trading Thursday, the Dow traded up 0.52% to 33,995.76 while the NASDAQ rose 0.13% to 14,069.67. The S&P also rose, gaining 0.50% to 4,204.22. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Gives Back Gains Amid Profit-Taking Spree
The major benchmarks are modestly higher this afternoon, as investors move to take profits following blowout earnings reports from Apple and Facebook. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Mid-Day Market Update: Nasdaq Turns Lower; Galera Therapeutics Shares Surge
Midway through trading Thursday, the Dow traded up 0.14% to 33,868.84 while the NASDAQ fell 0.33% to 14,004.20. The S&P also rose, gaining 0.15% to 4,189.46. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
54 Stocks Moving In Thursday's Mid-Day Session
Gainers Willamette Valley Vineyards, Inc. (NASDAQ: WVVI) climbed 40.5% to $14.39. Dolphin Entertainment, Inc. (NASDAQ: DLPN) shares gained 23.1% to $14.14. Dolphin Entertainment... 
Via Benzinga
Why Cara Therapeutics Stock Is Crashing Today
The company reported disappointing results from a phase 2 study. 
Via The Motley Fool
Mid-Morning Market Update: Markets Open Higher; McDonald's Profit Beats Estimates
Following the market opening Thursday, the Dow traded up 0.23% to 33,899.83 while the NASDAQ rose 0.25% to 14,086.11. The S&P also rose, gaining 0.49% to 4,203.60. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... 
Via Benzinga
Cara Therapeutics' Stock Plummets As Korsuva Flunks In Mid-Stage Atopic Dermatitis Study
Cara Therapeutics Inc (NASDAQ: CARA) shares dive after as investors react to topline results from its KARE Phase 2 trial evaluating oral Korsuva (... 
Via Benzinga
Cannabis Stock Gainers And Losers From April 23, 2021
GAINERS: Tetra Bio Pharma (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From April 19, 2021
GAINERS: General Cannabis (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From April 14, 2021
GAINERS: Claritas Pharmaceuticals (... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 6) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Second Sight Medical (NASDAQ:EYES) stock increased by 33.37% to $9.87 during Tuesday's regular session. As of 12:32 EST, this security is trading at a volume... 
Via Benzinga
51 Biggest Movers From Yesterday
Gainers UTime Limited (NASDAQ: UTME) shares jumped 875% to close at $39.00 on Tuesday after the company priced its IPO at $4 per share. Romeo Power, Inc. (NYSE: RMO) climbed 59.6... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.